Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06344884 · ClinicalTrials.gov registry record · NA

Early Patient Removal of Urinary Catheters After Urogynecologic Surgery

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
128
Enrollment target

NCT06344884: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT06344884 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06344884, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

Management of postoperative urinary retention often requires the use of indwelling catheters. In a previous study, the investigators determined that patient removal of catheters at home is non-inferior to standard office removal on postoperative day three or four (POD3-4). The purpose of this study is to determine whether patient removal of catheters at home on postoperative day one (POD1) is noninferior to removal on POD 3-4.

Primary Outcome

Defined as need for catheter replacement or clean intermittent self catheterization (CISC) after catheter removal on POD1 vs POD3-4. A 95% confidence interval of the difference in proportions between the two groups will be used to assess the tenability of a non-inferiority proposition.

Interventions

  • PROCEDURE Early catheter removal

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2024-06-24
Est. Completion 2025-11-19
Phase NA

What the finished NCT06344884 record still lists

NCT06344884 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Early catheter removal is the first listed.

NCT06344884 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06344884 about?

NCT06344884 is a clinical study titled "Early Patient Removal of Urinary Catheters After Urogynecologic Surgery". Management of postoperative urinary retention often requires the use of indwelling catheters. In a previous study, the investigators determined that patient removal of catheters at home is non-inferior to standard office removal on postoperative day three or four (POD3-4). The purpose of this study ...

What is the current status of trial NCT06344884?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2024-06-24. Estimated completion is 2025-11-19.

What interventions are being tested in trial NCT06344884?

The interventions under investigation include: Early catheter removal (PROCEDURE).

Who is sponsoring clinical trial NCT06344884?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06344884's enrollment target sits among peer trials

128 744th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02870738 · 128 participants · Phase 2

    Bladder Directed vs. Pelvic Floor Therapy in IC/BPS

  • NCT03294460 · 128 participants · Phase 1

    Nicotinic Receptor Genetic Variation and Alcohol Reward

  • NCT04149977 · 128 participants · NA

    Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

  • NCT04373057 · 128 participants · Phase 1

    Prebiotic Galacto-oligosaccharide and Acute GVHD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06344884, the US trial registry maintained by the National Library of Medicine. NCT06344884 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.